RecruitingMigraine
Effectiveness of Magnesium in Addition to Prochlorperazine for the Treatment of Migraines
Eligible age
18+ yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The purpose of this research study is to find out if using magnesium in addition to prochlorperazine will help reduce your migraine pain.
Sponsor: Wake Forest University Health Sciences
You may qualify if…
- ✓ Age ≥ 18 years or older
- ✓ Able to provide informed consent
- ✓ English speaking
- ✓ Primary diagnosis of migraine. Patient with a previous diagnosis of migraine, who experience headaches with typical migraine features (e.g at least 2-3 of the following: recurrent, unilateral, pounding or throbbing in nature, associated with nausea), AND with a clinical exclusion of migraine mimics
You may not qualify if…
- ✕ Pregnancy defined as a positive urine HCG
- ✕ Allergy or sensitivity to study drug
- ✕ Stated history of renal insufficiency
- ✕ Documented history of myasthenia gravis
- ✕ Consumption of study drug within 48 hours prior to enrollment
- ✕ Previously enrolled in this trial during a different patient encounter
Where it's recruiting
Illinois
Oak Lawn
Source: ClinicalTrials.gov · NCT06904287 · last updated 2026-01-22